Luo J, Wang Y, Yasuda R P, Dunah A W, Wolfe B B
Department of Pharmacology, Georgetown University School of Medicine, Washington, D.C. 20007, USA.
Mol Pharmacol. 1997 Jan;51(1):79-86. doi: 10.1124/mol.51.1.79.
A monoclonal antibody (R1JHL) against the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor has been developed that recognizes an epitope in the region of the amino-terminal amino acids 341-561 (a region common to all splice variants of NR1). This monoclonal antibody identifies a broad band at 115 kDa in immunoblots using membranes from NR1-transfected cells and from rat brain tissue. No cross-reactivity with any NR2 subunit is seen. With the goal to determine quantitatively the subunit composition of cortical NMDA receptors, we used the monoclonal antibody to NR1 and polyclonal antibodies against the NR2A and NR2B subunits to perform immunoprecipitations of receptor subunits from solubilized adult rat cortical membranes. Solubilization of the receptor subunits was accomplished under both nondenaturing (native) conditions, under which the subunits seem to remain associated with one another, and denaturing conditions, under which the subunits are associated from each other. Although each of these antibodies selectively immunoprecipitates only its corresponding (cognate) subunit when the subunits have been solubilized under denaturing conditions, each of the antibodies immunoprecipitates a sizable fraction of the other two NMDA receptor subunits when membranes are solubilized under nondenaturing conditions, indicating an interaction in situ. Using quantitative immunoblot analysis of the three subunits in both the pellets and supernatants from the immunoprecipitations, we found 1) the dominant NMDA receptor complex in adult rat cortex contains at least three subunits, NR1/NR2A/NR2B; 2) a smaller fraction of NMDA receptors are composed of only two subunits, NR1/NR2B or NR1/NR2A; 3) there are no complexes that contain NR2A/NR2B that do not contain NR1; 4) only a small fraction of each subunit is not associated with any other NMDA receptor subunit; 5) no coimmunoprecipitation of noncognate subunits occurs unless the subunits are assembled with each other in situ; and 6) there is no physical interaction between these NMDA receptor subunits and the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 or GluR3 subunits. These results suggest that functional studies with recombinant receptors composed of at least three subunits may be the most physiologically meaningful.
一种针对N-甲基-D-天冬氨酸(NMDA)受体NR1亚基的单克隆抗体(R1JHL)已被研制出来,它能识别氨基末端氨基酸341 - 561区域(NR1所有剪接变体共有的区域)中的一个表位。使用来自NR1转染细胞和大鼠脑组织的膜进行免疫印迹时,这种单克隆抗体在115 kDa处识别出一条宽带。未观察到与任何NR2亚基的交叉反应。为了定量确定皮质NMDA受体的亚基组成,我们使用针对NR1的单克隆抗体以及针对NR2A和NR2B亚基的多克隆抗体,对成年大鼠皮质膜溶解产物中的受体亚基进行免疫沉淀。受体亚基的溶解在非变性(天然)条件下完成,在此条件下亚基似乎彼此保持结合,以及在变性条件下完成,在此条件下亚基相互解离。当亚基在变性条件下溶解时,这些抗体中的每一种仅选择性地免疫沉淀其相应(同源)亚基,但当膜在非变性条件下溶解时,每种抗体都会免疫沉淀相当一部分其他两种NMDA受体亚基,这表明原位存在相互作用。通过对免疫沉淀的沉淀和上清液中这三种亚基进行定量免疫印迹分析,我们发现:1)成年大鼠皮质中主要的NMDA受体复合物至少包含三个亚基,即NR1/NR2A/NR2B;2)一小部分NMDA受体仅由两个亚基组成,即NR1/NR2B或NR1/NR2A;3)不存在不含NR1的包含NR2A/NR2B的复合物;4)每个亚基中只有一小部分不与任何其他NMDA受体亚基结合;5)除非亚基在原位相互组装,否则不会发生非同源亚基的共免疫沉淀;6)这些NMDA受体亚基与α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体GluR2或GluR3亚基之间不存在物理相互作用。这些结果表明,对由至少三个亚基组成的重组受体进行功能研究可能在生理上最有意义。